Tocilizumab ( 托珠单抗 )

产品名称：Tocilizumab ( 托珠单抗 )；

产品编号：YR1014；

分子名称：Tocilizumab；

克隆性：Monoclonal；

产品别称：Atlizumab, Tocilizumab；

关键词：Anti-Human IL6R Therapeutic AntibodyAtlizumab, MRA/R-1569/RHPM-1/RO-4877533, Anti-Human IL6R Therapeutic Antibody, Tocilizumab, 托珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG1；

宿主：Mouse；

CAS号：375823-41-9；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：；

产品背景：Tocilizumab (INN, trade name Actemra), also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children.；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：ELISA, FC, IP, FuncS, IF, Neut, ICC；